New target for cancer therapy identified by Australian researchers

	Tweet

A new target for cancer therapy has been identified by Monash University scientists investigating the cell signalling pathways that turn on a gene involved in cancer development.

A team led by Associate Professor Jun-Ping Liu, from the Department of Immunology, has identified two proteins that are involved in stopping the gene from producing a protein called telomerase that is essential if cancer cells are to proliferate.

Telomerase plays a key role in controlling the life span of cells by modifying structures called telomeres that are found at the end of chromosomes.

Although it is involved in tumour development, telomerase is also found in modest quantities in most cells. It is plentiful in stem cells where it keeps the telomeres long, allowing the cells to keep dividing without limit which is necessary for the repair of damaged and worn out tissues throughout the human body.

However, studies have shown that telomerase also plays a key role in the formation of cancerous tumours. “It’s the best indicator of cancer - 85 per cent better than any other tumour marker,” Associate Professor Liu said. “What’s more, telomerase is not associated with benign tumours; it’s a marker for malignant tumours only.

“If we can control the production of telomerase we can prevent the immortality of cancer cells and therefore cancer formation.”

Associate Professor Liu and his colleagues have been investigating breast cancer cells to identify the molecular signalling that is required to turn on, and also inhibit, the gene that produces telomerase. They have found two proteins Smad3 and c-Myc that are involved in turning off telomerase production. Their findings are published in the current issue of the Journal of Biological Chemistry.

“It’s significant to find inhibitors of telomerase and we have found, for the first time, the pathway that inhibits telomerase in human cells,” Associate Professor Liu said.

“This reveals an important mechanism for developing anti-cancer agents that mimic these proteins and thereby inhibit the production of telomerase. “

http://www.monash.edu.au

RELATED STORIES:
Drug Therapy to Bolster Immune System Cells Found Effective Toward Childhood Cancer   Some tumors contain factors that may block metastasis   The solitary pulmonary nodule - malignant or benign?   Algorithm Ranks Genes’ Likelihood to Contribute to Cancer   Childhood cancer survivors face limitations   How to Prevent Radiation Mistakes in Cancer Patients   Mobile phones don’t hike cancer risk: Danish study   Researchers Discover Second Protective Role for Tumor-Suppressor   American men with cancer more likely to die than women   New atlases detail global cancer burden   Childhood cancer survival linked to suicidality   Scientists detect cancer genes with new algorithm   Mount Sinai researchers discover possible new target for sarcoma treatment and prevention   Broccoli may help beat bladder cancer   Tumor mechanism identified   Dying at home better for cancer patients   Molecular discovery suggests new strategy to fight cancer drug resistance   Newly Found Enzymes May Play Early Role in Cancer   Novel device uses light to probe for early signs of cancer   Internet Research Builds Cancer Patients’ Confidence   Brain metastases hijack neuron-supporting cells to resist chemotherapy   Just how safe is that steak?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]